These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15991679)

  • 21. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
    Meyer C; McGrath BP; Teede HJ
    Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Kavŭrdzhikova S
    Akush Ginekol (Sofiia); 2006; 45(6):29-35. PubMed ID: 17168480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovary syndrome in adolescence--a therapeutic conundrum.
    Homburg R; Lambalk CB
    Hum Reprod; 2004 May; 19(5):1039-42. PubMed ID: 15016769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome.
    Essah PA; Apridonidze T; Iuorno MJ; Nestler JE
    Fertil Steril; 2006 Jul; 86(1):230-2. PubMed ID: 16716324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use and diabetic pregnancy-has its time come?
    Hawthorne G
    Diabet Med; 2006 Mar; 23(3):223-7. PubMed ID: 16492202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.
    Glueck CJ; Goldenberg N; Pranikoff J; Loftspring M; Sieve L; Wang P
    Hum Reprod; 2004 Jun; 19(6):1323-30. PubMed ID: 15117896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD; Strucchi C; Luisi M; Casarosa E; Lanzoni C; Baraldi E; Ricchieri F; Mehmeti H; Genazzani AR
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
    Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
    Kumbak B; Kahraman S
    Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased insulin sensitivity by metformin enhances intense-pulsed-light-assisted hair removal in patients with polycystic ovary syndrome.
    Rezvanian H; Adibi N; Siavash M; Kachuei A; Shojaee-Moradie F; Asilian A
    Dermatology; 2009; 218(3):231-6. PubMed ID: 19092235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA; Bradley HM; McCormick C; Witkop CT
    Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH; Khalid R; Naru T; Rizvi J
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is metformin therapy for polycystic ovary syndrome safe during pregnancy?
    Brock B; Smidt K; Ovesen P; Schmitz O; Rungby J
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):410-2. PubMed ID: 15910403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug treatments for polycystic ovary syndrome.
    Radosh L
    Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.